Artemis Technologies Secures $20M in Federal Contracts for Rabies Vaccine Production
The big picture: Artemis Technologies Inc., a Canadian biological product manufacturer, has been awarded over $20 million in federal contracts by the U.S. Animal and Plant Health Inspection Service (APHIS) for oral rabies vaccine baits.
Why it matters: These significant federal contracts highlight a specialized niche in biological manufacturing, potentially impacting skilled labor demand and supply chain stability for critical public health initiatives.
Between the lines:
- The contracts span from April 2024 to September 2026, totaling 9 awards across 13 transactions.
- All awards were for
